Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Egile nagusia: | Tania, Umme |
---|---|
Beste egile batzuk: | Khan, Tanisha |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
Brac University
2023
|
Gaiak: | |
Sarrera elektronikoa: | http://hdl.handle.net/10361/18736 |
Antzeko izenburuak
-
A review on targeted therapies for lung cancer
nork: Ashraf, Anushey
Argitaratua: (2023) -
Molecules associated with the development of lung cancer
nork: Rahman, Adree, et al.
Argitaratua: (2023) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
nork: Paul, Pulock
Argitaratua: (2024) -
Protein biomarkers for Lung Cancer: a bioinformatic approach
nork: Jeba, Joynob
Argitaratua: (2017) -
Potential of liposomes for the treatment of lung cancer- a review
nork: Mim, Shanzida
Argitaratua: (2023)